Article · 19 Jun 2026
Conference abstract
Why do we need pharmacovigilance in India?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
According to various estimates, Adverse Drug Reactions occur in 10-20% of hospital inpatients, account for 2-6 % of all hospital admissions, and are among top 10 causes of death in inpatients. Overall incidence of serious ADRs is about 6. 7 % and for fatal ADRs it is 0.32%. 15-20% of hospital budget may be spent dealing with drug complications. 30% to 60% of ADRs are preventable. More than 121 medicines were withdrawn for safety reasons in last 40 years- 33% within 2 years of marketing, 50% within 5 years. Tests in animals may not predict human safety. In clinical trials, patients are few, selection is narrow, indications are limited and time is brief. Therefore, information about rare but serious adverse effects, chronic toxicity, use in special groups and drug interactions often are incomplete or not available. Pharmacovigilance helps by early detection of unknown ADRs, detection of increase in frequency of ADRs, identification of risk factors and possible mechanisms underlying ADRs, estimation of benefit/risk, dissemination of information and taking necessary actions e.g., ban/withdraw the drug, insert suitable warnings, restrict use, modify OTC/prescription only status. Why do we need Pharmacovigilance in India? There are differences in ADRs between countries because of differences in drug availability, use, genetics, diet, pharmaceutical quality, use of alternative medicines, OTC availability of ?prescription only? drugs, multiple systems of healthcare. Moreover, Indian Pharmaceutical industry is worth more than Rs. 90,000 crores & growing at 12-14% per annum. India is the global clinical trial hub and there is almost simultaneous global introduction of new medicines.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmacovigilance.
Article · 19 Jun 2026
Strengthening Healthcare Outcomes Through Effective Drug Safety Practices
Article · 19 Jun 2026
Expanding Patient Care Through Clinical Pharmacy Services in Modern Healthcare
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacovigilance
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ratinder Jhaj”

